Trios Pharmaceuticals Private Limited
About Trios Pharmaceuticals Private Limited
Data last updated:
Trios Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 October 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL2005PTC142226. Its GSTIN is 06AACCT4985A1ZF (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Amit Bhatia and Sunil Kumar.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at H No 92 – Aparteek Market Munirka, New Delhi, Delhi, India – 110067.
As per the financials filed for FY 2019, the company reported a revenue of ₹29.68 Lakh, a decline of 19% compared to the previous year. For the same year it recorded a net loss of ₹31,443 (net margin -1.1%) and EBITDA of ₹3.22 Lakh (EBITDA margin 10.9%). Revenue has declined at a compounded annual rate (CAGR) of 39% over three years.
As per MCA filings, the company has open charges of ₹20 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Trios Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressH No 92 – Aparteek Market Munirka, New Delhi, Delhi, India – 110067
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Trios Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Trios Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Trios Pharmaceuticals Private Limited, buy the company report.
Financials of Trios Pharmaceuticals Private Limited
FY 2019 filings availableTrios Pharmaceuticals Private Limited reported revenue of ₹29.68 Lakh (down 19% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 39% over three years, including a 19% fall in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹29.68 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.22 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹31,443 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.9% | ||||
| Net Profit Margin | -1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Trios Pharmaceuticals Private Limited, buy the company report.
Board of directors of Trios Pharmaceuticals Private Limited
Trios Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Bhatia | Director | 31 Oct 2005 | 20 Years 11 Months | Current |
| Sunil Kumar | Director | 01 Sep 2015 | 11 Years 1 Months | Current |
Auditor
Trios Pharmaceuticals Private Limited is audited by ARVIND KRISHAN ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARVIND KRISHAN ASSOCIATES | FY 2017 | 016115N |
Shareholding
The shareholding of Trios Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Trios Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Dec 2015 | 10617447 | Icici Bank | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Trios Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Karnal, Haryana | Cheque dishonour complaint | Filed against the company by M/S Pylon Pharmaceuticals Through Its Prop Subhash Chand | Disposed |
To see the full case history of Trios Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Trios Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Trios Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AACCT4985A1ZF | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Trios Pharmaceuticals Private Limited, buy the company report.
Recent activity
Trios Pharmaceuticals Private Limited has 4 board changes on record since 2005: 2 appointments and 2 cessations. The latest: Sachin ceased to be Director on 08 Sep 2015.
Frequently asked questions
Trios Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 October 2005 (21+ years old) and is registered under CIN U24231DL2005PTC142226.
Trios Pharmaceuticals has 2 current directors:
- Amit Bhatia - Director
- Sunil Kumar - Director
The latest financial statements of Trios Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
The GSTIN of Trios Pharmaceuticals is 06AACCT4985A1ZF, registered in Haryana.
The CIN (Corporate Identification Number) of Trios Pharmaceuticals is U24231DL2005PTC142226. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Trios Pharmaceuticals has 1 court case on record: 1 filed against it.
Trios Pharmaceuticals was incorporated on 31 October 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
Sachin ceased to be Director on 08 Sep 2015. Sunil Kumar was appointed as Director on 01 Sep 2015. Anil Kumar Malik ceased to be Director on 12 Sep 2009. Trios Pharmaceuticals has 4 board changes on record in total.
The registered office of Trios Pharmaceuticals is at H No 92 – Aparteek Market Munirka, New Delhi, Delhi, India – 110067.
Trios Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.